Andere talen Shattuck Labs, Inc.

Aandelen

STTK

US82024L1035

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,78 ^USD	-2,88%		+1,79%	+51,19%

02/05	Shattuck Labs, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
04/03	Shattuck Labs, Inc. Kondigt bestuursbenoemingen aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Shattuck Labs : May 02, 2023 Shattuck Labs Corporate Presentation	02/05
Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights	02/05
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024	09/04
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference	01/04
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors	04/03
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors	04/03
Shattuck Labs, Inc. Announces Board Appointments	04/03
Sector Update: Health Care Stocks Rising Late Afternoon	01/03
Sector Update: Health Care Stocks Advance Friday Afternoon	01/03
Shattuck Labs Shares Rise as Q4 Net Loss Narrows	01/03
Shattuck Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights	29/02
Shattuck Labs, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights	29/02
Shattuck Labs Announces Participation in Upcoming March Conferences	26/02
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins	14/02
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins	14/02
Shattuck Strikes Joint Development Deal With Japan's Ono Pharma	13/02
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases	13/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shattuck Labs, Inc.

Aandelen

STTK

US82024L1035

Andere talen

Filters